Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2017 1
2018 1
2019 1
2020 3
2022 4
2023 1

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations.
van Dam KPJ, Wieske L, Stalman EW, Kummer LYL, Roosen J, van Kempen ZLE, Killestein J, Volkers AG, Boekel L, Wolbink GJ, van der Kooi AJ, Raaphorst J, Löwenberg M, Takkenberg RB, D'Haens GRAM, Spuls PI, Bekkenk MW, Musters AH, Post NF, Bosma AL, Hilhorst ML, Vegting Y, Bemelman FJ, Voskuyl AE, Broens B, Sanchez AP, van Els CACM, de Wit J, Rutgers A, de Leeuw K, Horváth B, Verschuuren JJGM, Ruiter AM, van Ouwerkerk L, van der Woude D, Allaart RCF, Teng YKO, van Paassen P, Busch MH, Jallah PBP, Brusse E, van Doorn PA, Baars AE, Hijnen DJ, Schreurs CRG, van der Pol WL, Goedee HS, Steenhuis M, Keijzer S, Keijser JBD, Cristianawati O, Rispens T, Brinke AT, Verstegen NJM, Marieke van Ham S, Tas SW, Kuijpers TW, Eftimov F; T2B! Immunity against SARS-CoV-2 study group. van Dam KPJ, et al. Among authors: brinke at. J Autoimmun. 2023 Feb;135:102984. doi: 10.1016/j.jaut.2022.102984. Epub 2023 Jan 2. J Autoimmun. 2023. PMID: 36621174 Free PMC article.
Systematic Assessment of Difficult-to-Treat Asthma: Principles and Perspectives.
Hew M, Menzies-Gow A, Hull JH, Fleming L, Porsbjerg C, Brinke AT, Allen D, Gore R, Tay TR. Hew M, et al. Among authors: brinke at. J Allergy Clin Immunol Pract. 2020 Jul-Aug;8(7):2222-2233. doi: 10.1016/j.jaip.2020.02.036. Epub 2020 Mar 12. J Allergy Clin Immunol Pract. 2020. PMID: 32173508 Review.
Treatment Eligibility of Real-Life Mepolizumab-Treated Severe Asthma Patients.
Richards LB, van Bragt JJMH, Aarab R, Longo C, Neerincx AH, Sont JK, Weersink EJM, Braunstahl GJ, Brinke AT, Bel EHD, Maitland-van der Zee AH. Richards LB, et al. Among authors: brinke at. J Allergy Clin Immunol Pract. 2020 Oct;8(9):2999-3008.e1. doi: 10.1016/j.jaip.2020.04.029. Epub 2020 Apr 25. J Allergy Clin Immunol Pract. 2020. PMID: 32344189
Alpine altitude climate treatment for severe and uncontrolled asthma: An EAACI position paper.
Fieten KB, Drijver-Messelink MT, Cogo A, Charpin D, Sokolowska M, Agache I, Taborda-Barata LM, Eguiluz-Gracia I, Braunstahl GJ, Seys SF, van den Berge M, Bloch KE, Ulrich S, Cardoso-Vigueros C, Kappen JH, Brinke AT, Koch M, Traidl-Hoffmann C, da Mata P, Prins DJ, Pasmans SGMA, Bendien S, Rukhadze M, Shamji MH, Couto M, Oude Elberink H, Peroni DG, Piacentini G, Weersink EJM, Bonini M, Rijssenbeek-Nouwens LHM, Akdis CA. Fieten KB, et al. Among authors: brinke at. Allergy. 2022 Jul;77(7):1991-2024. doi: 10.1111/all.15242. Epub 2022 Feb 15. Allergy. 2022. PMID: 35113452 Free PMC article.
Associations Between Symptoms, Donor Characteristics and IgG Antibody Response in 2082 COVID-19 Convalescent Plasma Donors.
Vinkenoog M, Steenhuis M, Brinke AT, van Hasselt JGC, Janssen MP, van Leeuwen M, Swaneveld FH, Vrielink H, van de Watering L, Quee F, van den Hurk K, Rispens T, Hogema B, van der Schoot CE. Vinkenoog M, et al. Among authors: brinke at. Front Immunol. 2022 Feb 28;13:821721. doi: 10.3389/fimmu.2022.821721. eCollection 2022. Front Immunol. 2022. PMID: 35296077 Free PMC article.
Longitudinal SARS-CoV-2 humoral response in MS patients with and without SARS-CoV-2 infection prior to vaccination.
van Dam KPJ, Hogenboom L, Stalman EW, Kummer LYL, Steenhuis M, Keijser JBD, Brinke AT, van Ham SM, Kuijpers TW, Rispens T, Wieske L, Eftimov F, Strijbis EM, Killestein J, van Kempen ZLE. van Dam KPJ, et al. Among authors: brinke at. Front Neurol. 2022 Nov 10;13:1032830. doi: 10.3389/fneur.2022.1032830. eCollection 2022. Front Neurol. 2022. PMID: 36438945 Free PMC article.
Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod.
Palomares Cabeza V, Kummer LYL, Wieske L, Hagen RR, Duurland M, Konijn VAL, van Dam KPJ, Stalman EW, van de Sandt CE, Boekel L, Verstegen NJM, Steenhuis M, Rispens T, Tas SW, Wolbink G, Killestein J, Kuijpers TW, van Ham SM, Eftimov F, Brinke AT, van Kempen ZLE; Target-to-B! (T2B!) SARS-CoV-2 study group. Palomares Cabeza V, et al. Among authors: brinke at. Neurol Neuroimmunol Neuroinflamm. 2022 May 6;9(4):e1178. doi: 10.1212/NXI.0000000000001178. Print 2022 Jul. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 35523569 Free PMC article.
11 results